生物活性 靶点 体外研究 体内研究
ChemicalBook  CAS数据库列表  sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate

sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate

sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate,496807-11-5,结构式
sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate
  • CAS号:496807-11-5
  • 英文名:sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate
  • 中文名:sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate
  • CBNumber:CB53400703
  • 分子式:C24H31NaO5
  • 分子量:422.5
  • MOL File:496807-11-5.mol
sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate化学性质
  • 储存条件 :Store at -20°C
  • 溶解度 :DMSO: 250 mg/mL (594.57 mM)
  • 形态 :Solid
  • 颜色 :White to light yellow

sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate性质、用途与生产工艺

  • 生物活性 Beraprost sodium 是一种前列环素类似物,是一种稳定且具有口服活性的 PGI2 前药。Beraprost sodium 是有效的血管扩张剂 (vasodilator),通过扩张肾血管,改善微循环而具有研究肺动脉高压的潜力。
  • 靶点

    prodrug of PGI2; Vasodilator

  • 体外研究

    Beraprost sodium (0.1, 1.0, and 10.0 μM; 24 hours) treatment leads to a significant increase in the number of tube formation, BPS plays an important role on angiogenic activity. Beraprost sodium (0.1, 1.0, and 10.0 μM; 24 hours) treatment let VE-cadherin at regions of cell–cell contact becomes more abundant and the morphology of endothelial cells tends to be normal compared with those cultured under hypoxia conditions.

  • 体内研究

    Beraprost sodium (oral adminstration; 0.6 mg/kg; once daily; 3 or 7 days) can mitigate the development of renal interstitial fibrosis, decrease renal oxidative stress through its potential vasodilation effect, and further prevent renal interstitial fibrosis.

    Animal Model: 6-8-week-old C57Bl/6J Male Mice
    Dosage: 0.6 mg/kg
    Administration: Oral adminstration; 0.6 mg/kg; once daily; 3 or 7 days
    Result: Mitigated the development of renal interstitial fibrosis.
sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate上下游产品信息
上游原料
下游产品
sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate生产厂家
  • 公司名称:TargetMol中国(陶术生物)
  • 联系电话:021-021-33632979 15002134094
  • 电子邮件:marketing@targetmol.com
  • 国家:中国
  • 产品数:7854
  • 优势度:58
  • 公司名称:广州市桐晖药业有限公司
  • 联系电话:020-61855200 13326451905
  • 电子邮件:260366801@qq.com
  • 国家:中国
  • 产品数:7573
  • 优势度:58
  • 公司名称:ChemeGen 中国
  • 联系电话: 18818260767
  • 电子邮件:sales@chemegen.com
  • 国家:中国
  • 产品数:11289
  • 优势度:58
  • 公司名称:广州佳途科技股份有限公司
  • 联系电话:020-81960175-877 18933936954
  • 电子邮件:tianwen.zhan@cato-chem.com
  • 国家:中国
  • 产品数:7721
  • 优势度:58
496807-11-5, sodium:4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate相关搜索: